Medicover Genetics

Berlin, Germany Founded: 1998 • Age: 28 yrs
Genetic tests for disease prediction, diagnosis, and prevention are offered.

About Medicover Genetics

Medicover Genetics is a Healthcare company based in Berlin (Germany) founded in 1998. Genetic tests for disease prediction, diagnosis, and prevention are offered. Its website medicover-genetics.com draws about 71 thousand monthly visits. Medicover Genetics offers products and services including Genetic Testing for Oncology and Genetic Testing for Rare Diseases. Its focus areas include Clinical Laboratories.

Company details

Medicover Genetics was founded in 1998 and is headquartered in Berlin, Germany. Operations are conducted in the genetics sector through a network of laboratories and medical institutions. An extensive portfolio of genetic testing services is provided, including cytogenetic analyses, molecular pathology solutions, Next Generation Sequencing technology, and microbiome sequencing. Over two decades of expertise in genetics and testing technologies are utilized to support healthcare professionals in patient care.

Operational Areas
Key Metrics

Products & Services of Medicover Genetics

Medicover Genetics offers a comprehensive portfolio of products and services, including Genetic Testing for Oncology and Genetic Testing for Rare Diseases.

Genetic Testing for Oncology
Diagnostic Services

Genetic testing is conducted for hereditary cancer and tumor profiles to detect mutations associated with cancer risks

Genetic Testing for Rare Diseases
Diagnostic Services

Genetic testing is performed for rare diseases, including panels for blood disorders and neurological conditions, to identify underlying genetic factors

Funding Insights of Medicover Genetics

  • Total Rounds 2
  • Last Round Grant β€” $183,956
  • First Round $159,915

    (Dec 2016)

  • Investors Count 1

All 2 funding rounds of Medicover Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$183,956Grant––
Dec 2016$159,915Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Medicover Genetics

Medicover Genetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Medicover Genetics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Medicover Genetics

14 people are tracked at Medicover Genetics (5 in leadership, 9 in team).

NameRoleGroup
Philippos Patsalis
CEOLeadership
Marina Hovakimyan
Head Of OperationsLeadership
Aleksandar Vasilevski
Sales DirectorLeadership
Kristine Janssens
Head Of SalesLeadership
Pepa Tanousis
Marketing And Communications DirectorLeadership
Olga Sarlidou
Medical Laboratory TechnologistTeam
Jonathan Parker
Business Development ManagerTeam
Adrian Ion
Finance Manager, Medicover GeneticsTeam
Loizos Zinonos
Laboratory TechnicianTeam
Stefani Antoniou
Laboratory SupervisorTeam
Stephanie Vounou
Laboratory Technologist ITeam
Andria Theodosi
LSOTeam
Daniel Tomaschewski
Vertriebsleiter Labordiagnostik/ GenetikTeam
Vesna Trpchevska
Business Development Manager For The BalkansTeam
Premium access

Complete people profiles for Medicover Genetics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Medicover Genetics

3 dated milestones of Medicover Genetics across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Medicover Genetics is founded.
  2. Funding First funding round of $160K.
  3. Funding Latest funding round, Grant, of $184K.

Web traffic of Medicover Genetics

The website of Medicover Genetics (medicover-genetics.com) receives about 71K visits a month.

  • Monthly visits
    71K

    ▼ 4.9% vs previous month

Similar websites

Websites whose visitors overlap most with Medicover Genetics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
fdna.com
81%
38KView details
fulgentgenetics.com
49%
37.8K#812,411View details
blueprintgenetics.com
48%
40.7K#816,872View details
medicover.com
44%
30.7KView details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Medicover Genetics

Medicover Genetics was founded in 1998 and raised its 1st funding round 18 years after it was founded.

Medicover Genetics is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

Medicover Genetics was founded in 1998 and is headquartered in Berlin, Germany. Operations are conducted in the genetics sector through a network of laboratories and medical institutions. An extensive portfolio of genetic testing services is provided, including cytogenetic analyses, molecular pathology solutions, Next Generation Sequencing technology, and microbiome sequencing. Over two decades of expertise in genetics and testing technologies are utilized to support healthcare professionals in patient care.

Medicover Genetics offers Genetic Testing for Oncology and Genetic Testing for Rare Diseases.

Medicover Genetics has 1 investor. Key investors include European Union.

Medicover Genetics operates through Medicover Genetics.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available